Research on AIS Recurrence Risk Prediction Model Using XGBoost Combined With Convolutional Neural Network Algorithm
1 other identifier
observational
2,628
1 country
1
Brief Summary
The purpose of this observational study is to construct a recurrence risk prediction model for ischemic stroke within 1, 3, 6, and 12 months using XGBoost combined with Convolutional Neural Network (CNN) algorithm. Method: Follow up was conducted on the study subjects at 1, 3, 6, and 12 months after discharge. Follow up primary outcome: Whether the study subjects experienced recurrent stroke events. Secondary outcome: Improved Rinkin score. Collect information on research subjects: It includes demographic data, physical examination, medical history, imaging images, medication use, scale scores, CYP2C19 genotype test results, laboratory tests, and other complex multidimensional data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFirst Submitted
Initial submission to the registry
January 13, 2025
CompletedFirst Posted
Study publicly available on registry
January 28, 2025
CompletedFebruary 21, 2025
February 1, 2025
1.9 years
January 13, 2025
February 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Recurrent ischemic stroke,
Follow up was conducted on the study subjects at 1, 3, 6, and 12 months after discharge, with the main outcome being whether the study subjects experienced stroke recurrence events
April 6th, 2021- March 12th, 2024
Secondary Outcomes (1)
modified Rankin score
April 6th, 2021- March 12th, 2024
Eligibility Criteria
Ischemic stroke patients treated in hospitals who meet the inclusion and exclusion criteria for the project
You may qualify if:
- Aged between 18-85 years
- Diagnosed with ischemic stroke or transient ischemic attack (diagnosis in accordance with the standards set by the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association in 2014)
- Within the acute phase of the illness (within 2 weeks)
- Voluntarily participates and signs an informed consent form
You may not qualify if:
- Patients with cancer
- Patients with cardiogenic infarction, other causes of cerebral infarction, or cryptogenic cerebral infarction
- Patients with hemorrhagic stroke, mixed stroke, and tumor stroke
- Patients with severe heart, lung, or liver system diseases
- Patients judged by the researcher to have poor compliance and unable to complete long-term follow-up
- Patients currently participating in any clinical trials related to investigational drugs or medical devices
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330008, China
Related Publications (1)
Liu J, Li J, Wu Y, Luo H, Yu P, Cheng R, Wang X, Xian H, Wu B, Chen Y, Ke J, Yi Y. Deep learning-based segmentation of acute ischemic stroke MRI lesions and recurrence prediction within 1 year after discharge: A multicenter study. Neuroscience. 2025 Jan 26;565:222-231. doi: 10.1016/j.neuroscience.2024.12.002. Epub 2024 Dec 2.
PMID: 39631660RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
yingping Y Yi
Second Affiliated Hospital of Nanchang University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2025
First Posted
January 28, 2025
Study Start
April 26, 2021
Primary Completion
March 4, 2023
Study Completion
December 31, 2024
Last Updated
February 21, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share